MITF Pathway-Activated Cutaneous Neoplasms

Michael Michal1, Steven D Billings2, Thomas Brenn3

  • 1Department of Pathology, Faculty of Medicine in Plzen, University Hospital Plzen, Charles University Plzen, Czech Republic Bioptical Laboratory Ltd, Pilsen, Czech Republic.

PubMed

Insights

Several dermal tumors activate the microphthalmia (MITF) pathway via gene fusions, leading to a melanocytic phenotype. Understanding these rare tumors, including clear cell sarcoma, is crucial for diagnosis and treatment.

Area of Science:

  • Oncology
  • Genetics
  • Dermatopathology

Background:

  • Dermal tumors can exhibit a melanocytic phenotype due to specific gene fusions.
  • Microphthalmia (MITF) signaling pathway activation is a common mechanism in these tumors.
  • Clear cell sarcoma, characterized by EWSR1 rearrangements, is a well-known example, though rare in the skin.

Purpose of the Study:

  • To provide a comprehensive overview of rare dermal tumors with MITF pathway activation.
  • To highlight the distinguishing features of various fusion-driven cutaneous tumors.
  • To aid in the differential diagnosis of these uncommon neoplasms.

Main Methods:

  • Review of recent scientific literature on cutaneous tumors with gene fusions.
  • Analysis of characteristic genetic alterations (e.g., EWSR1, CRTC1::TRIM11, ACTIN::MITF).
  • Comparison of clinical, histopathologic, and immunophenotypic features.

Main Results:

  • Multiple gene fusions (e.g., CRTC1::TRIM11, ACTIN::MITF, MITF::CREM, MED15::ATF1) have been identified in cutaneous tumors.
  • These tumors share a melanocytic phenotype and MITF pathway activation.
  • Subtle differences in presentation, histology, immunophenotype, and prognosis exist among these entities.

Conclusions:

  • Fusion genes play a significant role in the pathogenesis of a subset of rare dermal tumors.
  • Accurate differentiation requires careful evaluation of multiple clinicopathologic parameters.
  • Further research is needed to fully elucidate the behavior and optimal management of these tumors.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K